White paper
August 6, 2024

Scaling up HEK cell culture process from 250mL to 5L bioreactor with consistent performance in Culture Biosciences cloud-connected bioreactors

Human embryonic kidney cells are widely used in gene therapy and other therapeutic expression processes. They possess several key attributes that make them good hosts for genetic modification and gene therapy expression. Here we describe the growth of suspension adapted HEK293 cells in 250mL and 5L bioreactors. We monitored viable cell density and viability along with metabolites ammonium, lactate, and glutamine. All measurements reached the same end points, with viable cell density, viability, lactate and glutamine following similar trends between scales.

Complete the form to download the full PDF

Keep exploring

White paper

Growth and Site to Site Comparison of a HEK Fed-Batch Process in Stratyx™ 250

July 25, 2025
White paper

Stratyx™ 250 Comparison of CHO Process Characteristics in 250mL Bioreactor Systems

April 1, 2025